National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings, 67320-67321 [2018-28332]
Download as PDF
<![CDATA[
67320
Federal Register / Vol. 83, No. 248 / Friday, December 28, 2018 / Notices
Agenda: Evaluate sleep and circadian
research activities; discussion of NIH Sleep
Disorders Research Plan Revision.
Place: National Institutes of Health, Two
Rockledge Center, Conference Room 9100–
9104, 6701 Rockledge Drive, Bethesda, MD
20892.
Time: January 18, 2019, 8:30 a.m. to 3:00
p.m.
Agenda: Coordination of inter-agency sleep
research activities; discussion of NIH Sleep
Disorders Research Plan Revision.
Place: National Institutes of Health, Two
Rockledge Center, Conference Room 9100–
9104, 6701 Rockledge Drive, Bethesda, MD
20892.
Contact Person: Michael J. Twery, Ph.D.,
Director, National Center on Sleep Disorders
Research, Division of Lung Diseases, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6701 Rockledge Drive,
Suite 10042, Bethesda, MD 20892, 301–435–
0199, twerym@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: December 21, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28328 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lee G Klinkenberg, Ph.D.,
Scientific Review Program, DEA/NIAID/NIH/
DHHS, 5601 Fishers Lane, MSC–9823
Bethesda, MD 20892–9834, 301–761–7749,
lee.klinkenberg@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: January 30–31, 2019.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Julio C. Aliberti, Ph.D.,
Scientific Review Officer, Immunology
Review Branch, DEA/SRP RM 3G53A,
National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Rockville, MD
20892–9823, 301–761–7322, julio.aliberti@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 20, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28341 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PAR–18–633: NIAID
Clinical Trial Implementation Cooperative
Agreement (U01 Clinical Trial Required).
Date: January 22, 2019.
Time: 2:30 p.m. to 4:00 p.m..
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:13 Dec 27, 2018
Jkt 247001
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 National
Resource Review (2019/05).
Date: February 7–9, 2019.
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
Time: 3:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn by Marriott Redwood
City San Carlos, 800 E. San Carlos Ave, San
Carlos, CA.
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard., Suite 957, Bethesda,
MD 20892, 301–496–4773, zhour@
mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC Review
(2019/05).
Date: February 8, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Biomedical Imaging and
Bioengineering, Two Democracy Plaza, Suite
920, 6707 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3397, sukharem@
mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC Review
Meeting (2019/05).
Date: February 13–15, 2019.
Time: 12:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Shelburne Hotel & Suites by Affinia,
303 Lexington Avenue, New York, NY 10016.
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 952, Bethesda, MD
20892, (301) 451–3397, dennis.hlasta@
mail.nih.gov.
Dated: December 21, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28337 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\28DEN1.SGM
28DEN1
Federal Register / Vol. 83, No. 248 / Friday, December 28, 2018 / Notices
amozie on DSK3GDR082PROD with NOTICES1
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: March 4, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Alcohol Abuse and
Alcoholism, Conference Rooms A & B, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Anna Ghambaryan, M.D,
Ph.D., Scientific Review Officer, Extramural
Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700 B Rockledge
Drive, Room 2120, MSC 6902, Bethesda, MD
20892 301–443–4032, anna.ghambaryan@
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Neuroscience Review
Subcommittee.
Date: March 5, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Alcohol Abuse and
Alcoholism, Conference Room A & B, 6700
A Rockledge Drive, Bethesda, MD 20892.
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700 B Rockledge
Drive, Room 2116, MSC 6902, Bethesda, MD
20892 301–443–0800, bbuzas@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Biomedical Research Review
Subcommittee.
Date: March 12, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
National Institute of Alcohol Abuse and
Alcoholism, Conference Room A & B, 6700
A Rockledge Drive, Bethesda, MD 20892.
Contact Person: Philippe Marmillot, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, National Institute on Alcohol
Abuse and Alcoholism, National Institutes of
Health, 6700 B Rockledge Drive, Room 2118,
MSC 6902, Bethesda, MD, 20892, 301–443–
2861, marmillotp@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Review of Fellowship Grant
Applications.
Date: March 15, 2019.
VerDate Sep<11>2014
21:37 Dec 27, 2018
Jkt 247001
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Conference Rooms B & C, Bethesda, MD
20817.
Contact Person: Richard A. Rippe, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700 B Rockledge
Drive, Room 2109, MSC 6902, Bethesda, MD
20892, 301–443–8599, rippera@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Clinical Treatment and
Health Services Research Review
Subcommittee.
Date: March 29, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Alcohol Abuse and
Alcoholism, Conference Rooms B & C, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
Extramural Project Review Branch, National
Institutes of Health National Institute on
Alcohol Abuse and Alcoholism, 6700 B
Rockledge Drive, Room 2114, MSC 6902,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: December 21, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28332 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
67321
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 14–15, 2019.
Open: February 14, 2019, 12:30 p.m. to
6:00 p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Activities; and Administrative
and Program Developments.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A,
Convent Drive, Bethesda, MD 20892.
Closed: February 15, 2019.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A,
Convent Drive, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248, finkelsr@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into Federal buildings. Visitors will be asked
to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
https://www.ninds.nih.gov, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: December 20, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28339 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 83, Number 248 (Friday, December 28, 2018)]
[Notices]
[Pages 67320-67321]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-28332]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections
[[Page 67321]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Epidemiology, Prevention and
Behavior Research Review Subcommittee.
Date: March 4, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
Alcohol Abuse and Alcoholism, Conference Rooms A & B, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Anna Ghambaryan, M.D, Ph.D., Scientific Review
Officer, Extramural Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol Abuse and Alcoholism, 6700
B Rockledge Drive, Room 2120, MSC 6902, Bethesda, MD 20892 301-443-
4032, anna.ghambaryan@nih.gov.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Neuroscience Review Subcommittee.
Date: March 5, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
Alcohol Abuse and Alcoholism, Conference Room A & B, 6700 A
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Beata Buzas, Ph.D., Scientific Review Officer,
Extramural Project Review Branch, Office of Extramural Activities,
National Institute on Alcohol Abuse and Alcoholism, 6700 B Rockledge
Drive, Room 2116, MSC 6902, Bethesda, MD 20892 301-443-0800,
bbuzas@mail.nih.gov.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Biomedical Research Review
Subcommittee.
Date: March 12, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health National Institute of
Alcohol Abuse and Alcoholism, Conference Room A & B, 6700 A
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Philippe Marmillot, Ph.D., Scientific Review
Officer, Extramural Project Review Branch, National Institute on
Alcohol Abuse and Alcoholism, National Institutes of Health, 6700 B
Rockledge Drive, Room 2118, MSC 6902, Bethesda, MD, 20892, 301-443-
2861, marmillotp@mail.nih.gov.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; Review of Fellowship Grant
Applications.
Date: March 15, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Conference Rooms B & C, Bethesda, MD 20817.
Contact Person: Richard A. Rippe, Ph.D., Scientific Review
Officer, Extramural Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol Abuse and Alcoholism, 6700
B Rockledge Drive, Room 2109, MSC 6902, Bethesda, MD 20892, 301-443-
8599, rippera@mail.nih.gov.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Clinical Treatment and Health
Services Research Review Subcommittee.
Date: March 29, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
Alcohol Abuse and Alcoholism, Conference Rooms B & C, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D., Chief, Extramural
Project Review Branch, Extramural Project Review Branch, National
Institutes of Health National Institute on Alcohol Abuse and
Alcoholism, 6700 B Rockledge Drive, Room 2114, MSC 6902, Bethesda,
MD 20892, (301) 451-2067, srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: December 21, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-28332 Filed 12-27-18; 8:45 am]
BILLING CODE 4140-01-P
